These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
543 related articles for article (PubMed ID: 7537755)
21. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage. Wohn KD; Kanse SM; Deutsch V; Schmidt T; Eldor A; Preissner KT Thromb Haemost; 1997 Mar; 77(3):540-7. PubMed ID: 9066008 [TBL] [Abstract][Full Text] [Related]
22. Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas. Foca C; Moses EK; Quinn MA; Rice GE Gynecol Oncol; 2000 Nov; 79(2):244-50. PubMed ID: 11063652 [TBL] [Abstract][Full Text] [Related]
23. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta. Nishida Y; Hayashi Y; Imai Y; Itoh H Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056 [TBL] [Abstract][Full Text] [Related]
25. Regulation of urokinase plasminogen activator/plasmin-mediated invasion of melanoma cells by the integrin vitronectin receptor alphaVbeta3. Khatib AM; Nip J; Fallavollita L; Lehmann M; Jensen G; Brodt P Int J Cancer; 2001 Feb; 91(3):300-8. PubMed ID: 11169951 [TBL] [Abstract][Full Text] [Related]
26. Effect of alpha3beta1 and alphavbeta3 integrin glycosylation on interaction of melanoma cells with vitronectin. Janik ME; Przybyło M; Pocheć E; Pokrywka M; Lityńska A Acta Biochim Pol; 2010; 57(1):55-61. PubMed ID: 20066177 [TBL] [Abstract][Full Text] [Related]
27. Down-regulation of integrin alpha(v)beta(3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes. Adachi Y; Lakka SS; Chandrasekar N; Yanamandra N; Gondi CS; Mohanam S; Dinh DH; Olivero WC; Gujrati M; Tamiya T; Ohmoto T; Kouraklis G; Aggarwal B; Rao JS J Biol Chem; 2001 Dec; 276(50):47171-7. PubMed ID: 11572856 [TBL] [Abstract][Full Text] [Related]
28. Expression of the human gene encoding urokinase plasminogen activator receptor is activated by disruption of the cytoskeleton. Bayraktutan U; Jones P Exp Cell Res; 1995 Dec; 221(2):486-95. PubMed ID: 7493649 [TBL] [Abstract][Full Text] [Related]
29. Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cells. Perkins RC; Broaddus VC; Shetty S; Hamilton S; Idell S Am J Respir Cell Mol Biol; 1999 Nov; 21(5):637-46. PubMed ID: 10536123 [TBL] [Abstract][Full Text] [Related]
30. [Effect of vacuum-assisted closure on the expression of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in acute and chronic wounds healing]. Li YJ; Cao DY; Chen SZ Zhonghua Zheng Xing Wai Ke Za Zhi; 2006 Jul; 22(4):306-9. PubMed ID: 17017150 [TBL] [Abstract][Full Text] [Related]
31. Expression of vitronectin receptor on human NK cells and its role in protein phosphorylation, cytokine production, and cell proliferation. Rabinowich H; Lin WC; Amoscato A; Herberman RB; Whiteside TL J Immunol; 1995 Feb; 154(3):1124-35. PubMed ID: 7529790 [TBL] [Abstract][Full Text] [Related]
32. Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes. Yu HR; Schultz RM Cancer Res; 1990 Dec; 50(23):7623-33. PubMed ID: 1701350 [TBL] [Abstract][Full Text] [Related]
33. Relationship between urokinase-type plasminogen receptor, interleukin-8 gene expression and clinicopathological features in gastric cancer. Lee KH; Bae SH; Lee JL; Hyun MS; Kim SH; Song SK; Kim HS Oncology; 2004; 66(3):210-7. PubMed ID: 15218312 [TBL] [Abstract][Full Text] [Related]
34. Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix. Kruk PA; Uitto VJ; Firth JD; Dedhar S; Auersperg N Exp Cell Res; 1994 Nov; 215(1):97-108. PubMed ID: 7525326 [TBL] [Abstract][Full Text] [Related]
35. Loss of the metastatic phenotype by a human epidermoid carcinoma cell line, HEp-3, is accompanied by increased expression of tissue inhibitor of metalloproteinase 2. Testa JE Cancer Res; 1992 Oct; 52(20):5597-603. PubMed ID: 1327511 [TBL] [Abstract][Full Text] [Related]
36. Examination of the effects of epidermal growth factor on the production of urokinase and the expression of the plasminogen activator receptor in a human colon cancer cell line. Boyd D Cancer Res; 1989 May; 49(9):2427-32. PubMed ID: 2539903 [TBL] [Abstract][Full Text] [Related]
37. Plasminogen activator system in osteoclasts. Yang JN; Allan EH; Anderson GI; Martin TJ; Minkin C J Bone Miner Res; 1997 May; 12(5):761-8. PubMed ID: 9144342 [TBL] [Abstract][Full Text] [Related]
38. Expression of urokinase and its receptor in invasive and non-invasive prostate cancer cell lines. Hollas W; Hoosein N; Chung LW; Mazar A; Henkin J; Kariko K; Barnathan ES; Boyd D Thromb Haemost; 1992 Dec; 68(6):662-6. PubMed ID: 1337629 [TBL] [Abstract][Full Text] [Related]
39. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs. Shetty S; Kumar A; Johnson AR; Pueblitz S; Holiday D; Raghu G; Idell S Am J Respir Cell Mol Biol; 1996 Jul; 15(1):78-87. PubMed ID: 8679225 [TBL] [Abstract][Full Text] [Related]
40. Human melanoma cells derived from lymphatic metastases use integrin alpha v beta 3 to adhere to lymph node vitronectin. Nip J; Shibata H; Loskutoff DJ; Cheresh DA; Brodt P J Clin Invest; 1992 Oct; 90(4):1406-13. PubMed ID: 1383272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]